Influence of probucol on enhanced LDL oxidation after fish oil treatment of hypertriglyceridemic patients.
- 1 December 1993
- journal article
- abstracts
- Published by Wolters Kluwer Health in Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Vol. 13 (12) , 1790-1797
- https://doi.org/10.1161/01.atv.13.12.1790
Abstract
The susceptibility of low-density lipoprotein (LDL) to oxidation was studied in hypertriglyceridemic men (5 with type III and 5 with type IV) at baseline on a low-saturated-fat, low-cholesterol diet, after 6 weeks of dietary supplementation with fish oil (Promega, 12 g/d), and after 6 weeks of fish oil combined with probucol (500 mg BID). The relative content of n-3 polyunsaturated fatty acids in plasma and LDL was increased during the two treatment periods, and a low alpha-tocopherol to n-3 polyunsaturated fatty acids ratio was observed. Plasma thiobarbituric acid-reactive substances (TBARS) levels were unchanged after 6 weeks of fish oil, but the ratio of lipid peroxides to the reduced triglyceride (TG) levels (MDA:TG) was significantly higher (P < .01). Addition of probucol lowered both absolute levels of TBARS (P < .01) and the MDA to TG ratio (P < .001). The susceptibility of LDL to Cu(2+)-catalyzed oxidation was evaluated over a 5-hour time course by determining TBARS formation, free amino group levels, and changes in LDL electrophoretic mobility. TBARS levels that were higher in native LDL (1.019 < d < 1.050 g/mL) after 6 weeks of fish oil than at baseline (P < .01) were reduced 52.3 +/- 11.3% by the addition of probucol (P < .001). With fish oil alone, TBARS production after exposure of LDL to Cu2+ for 5 hours was increased 17.0 +/- 5.8% compared with corresponding baseline values (P < .001), whereas a 64.1 +/- 14.3% reduction from the previous period was observed with fish oil + probucol (P < .001).(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 33 references indexed in Scilit:
- Effect of low-dose probucol therapy on LDL oxidation and the plasma lipoprotein profile in male volunteersAtherosclerosis, 1992
- Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein. Use of a new water-soluble probucol derivative.Journal of Clinical Investigation, 1992
- Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle sizeAtherosclerosis, 1992
- Fish oil ingestion in smokers and nonsmokers enhances peroxidation of plasma lipoproteinsAtherosclerosis, 1991
- Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification.Journal of Clinical Investigation, 1991
- Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smokingAtherosclerosis, 1990
- Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitroAtherosclerosis, 1990
- Modification of low density lipoproteins from hypertriglyceridemic patients by macrophages in vitro and the effect of bezafibrate treatmentAtherosclerosis, 1989
- Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Long-term use of probucol in the multifactorial primary prevention of vascular diseaseThe American Journal of Cardiology, 1986